These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. What distinguishes the Olympic level heavyweight rowers from other internationally successful rowers? Mikulić P; Ruzić L; Oreb G Coll Antropol; 2007 Sep; 31(3):811-6. PubMed ID: 18041393 [TBL] [Abstract][Full Text] [Related]
49. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al. Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507 [No Abstract] [Full Text] [Related]
50. ACTN3 R577X polymorphism and Israeli top-level athletes. Eynon N; Duarte JA; Oliveira J; Sagiv M; Yamin C; Meckel Y; Sagiv M; Goldhammer E Int J Sports Med; 2009 Sep; 30(9):695-8. PubMed ID: 19544227 [TBL] [Abstract][Full Text] [Related]
51. The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Ahmetov II; Druzhevskaya AM; Lyubaeva EV; Popov DV; Vinogradova OL; Williams AG Exp Physiol; 2011 Dec; 96(12):1302-10. PubMed ID: 21930675 [TBL] [Abstract][Full Text] [Related]
52. Molecular basis of AMP deaminase deficiency in skeletal muscle. Morisaki T; Gross M; Morisaki H; Pongratz D; Zöllner N; Holmes EW Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6457-61. PubMed ID: 1631143 [TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in the control region of mitochondrial DNA associated with elite Japanese athlete status. Mikami E; Fuku N; Takahashi H; Ohiwa N; Pitsiladis YP; Higuchi M; Kawahara T; Tanaka M Scand J Med Sci Sports; 2013 Oct; 23(5):593-9. PubMed ID: 22288660 [TBL] [Abstract][Full Text] [Related]
54. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene. Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263 [TBL] [Abstract][Full Text] [Related]
55. Association of GABA(B)R1 receptor gene polymorphism with obstructive sleep apnea syndrome. Bayazit YA; Yilmaz M; Kokturk O; Erdal ME; Ciftci T; Gokdogan T; Kemaloglu Y; Ileri F ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):190-7. PubMed ID: 17264536 [TBL] [Abstract][Full Text] [Related]
56. Elite athletes: are the genes the champions? Lucía A; Morán M; Zihong H; Ruiz JR Int J Sports Physiol Perform; 2010 Mar; 5(1):98-102. PubMed ID: 20308700 [TBL] [Abstract][Full Text] [Related]
57. Variation in the HIF1A gene in elite rowers. Cięszczyk P; Kalinski M; Ostanek M; Jascaniene N; Krupecki K; Ficek K; Sawczuk M; Maciejewska A J Strength Cond Res; 2012 Dec; 26(12):3270-4. PubMed ID: 22476163 [TBL] [Abstract][Full Text] [Related]
58. The -9/+9 polymorphism of the bradykinin receptor Beta 2 gene and athlete status: a study involving two European cohorts. Sawczuk M; Timshina YI; Astratenkova IV; Maciejewska-Karlowska A; Leońska-Duniec A; Ficek K; Mustafina LJ; Cięszczyk P; Klocek T; Ahmetov II Hum Biol; 2013 Oct; 85(5):741-56. PubMed ID: 25078958 [TBL] [Abstract][Full Text] [Related]
59. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. Norman B; Mahnke-Zizelman DK; Vallis A; Sabina RL J Appl Physiol (1985); 1998 Oct; 85(4):1273-8. PubMed ID: 9760316 [TBL] [Abstract][Full Text] [Related]
60. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency. Rannou F; Scotet V; Marcorelles P; Monnoyer R; Le Maréchal C PLoS One; 2017; 12(11):e0187266. PubMed ID: 29095874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]